Comparative Analysis of Women’s Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia’s Amhara Region Using Parametric Shared Frailty Models

References

• Komen SG. Breast Cancer Fact Sheet; 2018. Available from: https://www.komen.org/uploadedFiles/Komen/Content/AboutUs/MediaCenter/Newsroom/breast-cancer-fact-sheet-august-2018.pdf. Accessed May 21, 2024.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394–424. doi:10.3322/caac.21492
   Web of Science ®Google Scholar
• Clegg-Lamptey JN. Epidemiology of Breast Cancer in Africa. Accra-Ghana: School of Medicine and Dentistry. University of Ghana; 2017.
   Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. 2011;61(2):69–90. doi:10.3322/caac.20107
   Google Scholar
• Timotewos G, Solomon A, Mathewos A, et al. First data from a population based cancer registry in Ethiopia. Cancer Epidemiol. 2018;53:93–98. doi:10.1016/j.canep.2018.01.008
   PubMed Web of Science ®Google Scholar
• Memirie ST, Habtemariam MK, Asefa M, et al. Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data. J Glob Oncol. 2018;4(4):1–11. doi:10.1200/JGO.17.00175
   PubMed Web of Science ®Google Scholar
• Lemlem SB, Sinishaw W, Hailu M, Abebe M, Aregay A. Assessment of knowledge of breast cancer and screening methods among nurses in university hospitals in Addis Ababa, Ethiopia, 2011. In: International Scholarly Research Notices. Hindawi; 2013.
   Google Scholar
• Legesse B, Gedif T. Knowledge on breast cancer and its prevention among women household heads in Northern Ethiopia. Open J Prev Med. 2014;04(01):32–40. doi:10.4236/ojpm.2014.41006
   Google Scholar
• Mohd-Zahid MH, Mohamud R, Abdullah CAC, et al. Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles. RSC Adv. 2020;10(2):973–985. doi:10.1039/C9RA08192E
   Web of Science ®Google Scholar
• Tesfaw A, Demis S, Munye T, Ashuro Z. Patient delay and contributing factors among breast cancer patients at two cancer referral centres in Ethiopia: a Cross-Sectional Study. J Multidiscip Healthc. 2020;13:1391. doi:10.2147/JMDH.S275157
   PubMed Web of Science ®Google Scholar
• Kantelhardt EJ, Zerche P, Mathewos A, et al. Breast cancer survival in Ethiopia: a cohort study of 1070 women. Int J Cancer. 2014;135(3):702–709. doi:10.1002/ijc.28691
   PubMed Web of Science ®Google Scholar
• Aalen O, Borgan O, Gjessing H. Survival and Event History Analysis: 582 a Process Point of View. Springer Science & Business Media; 2008.
   Google Scholar
• Hougaard P. Modelling heterogeneity in survival data. J Appl Probab. 1991;28(3):695–701. doi:10.2307/3214503
   Web of Science ®Google Scholar
• Van den Berg GJ. Duration models: specification, identification and multiple durations. In: Handbook of Econometrics. Vol. 5. Elsevier; 2001:3381–3460.
   Google Scholar
• Bennett S. Analysis of survival data by the proportional odds model. Stat Med. 1983;2(2):273–277. doi:10.1002/sim.4780020223
   PubMedGoogle Scholar
• Hougaard P. Survival models for heterogeneous populations derived from stable distributions. Biometrika. 1986;73(2):387–396. doi:10.1093/biomet/73.2.387
   Web of Science ®Google Scholar
• Caroni C, Crowder M, Kimber A. Proportional hazards models with discrete frailty. Lifetime Data Anal. 2010;16(16):374–384. doi:10.1007/s10985-010-9151-3
   PubMedGoogle Scholar
• Munda M, Rotolo F, Legrand C. parfm: parametric frailty models in R. Journal of Statistical Software. 2012;51(11):1–20. doi:10.18637/jss.v051.i11
   PubMed Web of Science ®Google Scholar
• Rueten Budde AJ, Putter H, Fiocco M. Investigating hospital heterogeneity with a competing risks frailty model. Stat Med. 2019;38(2):269–288. doi:10.1002/sim.8002
   PubMed Web of Science ®Google Scholar
• Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26(4):428–445. doi:10.1007/s12282-018-00941-4
   PubMed Web of Science ®Google Scholar
• Weiss MC, Ruderman J A Step-By-Step Guide to Reducing Your Risk of Breast Cancer; 2011.
   Google Scholar
• Allemani C, Weir HK, Carreira H, et al. G lobal surveillance of cancer survival 1995–2009: analysis of individual 611 data for 25 887 patients from 279 population-based registries in 67 countries (Concord-2). Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-9
   PubMed Web of Science ®Google Scholar
• Abedi G, Janbabai G, Moosazadeh M, Farshidi F, Amiri M, Khosravi A. Survival rate of breast cancer in Iran: a meta-analysis. Asian Pac J Cancer Prev. 2016;17(10):4615–4621. doi:10.22034/apjcp.2016.17.10.4615
   PubMedGoogle Scholar
• Fisch T, Pury P, Probst N, et al. Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol. 2005;16(12):1882–1888. doi:10.1093/annonc/mdi404
   PubMed Web of Science ®Google Scholar
• Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer. 2003;98(10):2133–2143. doi:10.1002/cncr.11765
   PubMed Web of Science ®Google Scholar
• Alotaibi RM, Guure C. Bayesian and Frequentist Analytical Approaches Using Log-Normal and Gamma Frailty Parametric Models for Breast Cancer Mortality. Comput Math Methods Med. 2020;2020:1–11. doi:10.1155/2020/9076567
   Web of Science ®Google Scholar
• Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J National Cancer Inst. 2011;103(14):1101–1111. doi:10.1093/jnci/djr188
   PubMedGoogle Scholar
• Yazdani A, Yaseri M, Haghighat S, Kaviani A, Zeraati H. Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: a Multicenter Study. Breast Cancer. 2019;13:1178223419879112. doi:10.1177/1178223419879112
   Web of Science ®Google Scholar
• Pathy NB, Yip CH, Taib NA, et al. Breast cancer in a multi-ethnic Asian setting: results from the Singapore–Malaysia hospital-based breast cancer registry. Breast. 2011;20:S75–S80. doi:10.1016/j.breast.2011.01.015
   PubMed Web of Science ®Google Scholar
• Ruiterkamp J, Voogd AC, Bosscha K, Tjan-Heijnen VC, Ernst MF. Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Res Treat. 2010;120(1):9–16. doi:10.1007/s10549-009-0670-0
   PubMed Web of Science ®Google Scholar
• Baghestani AR, Moghaddam SS, Majd HA, Akbari ME, Nafissi N, Gohari K. Survival analysis of patients with breast cancer using Weibull parametric model. Asian Pac J Cancer Prev. 2016;16(18):8567–8571. doi:10.7314/APJCP.2015.16.18.8567
   Google Scholar
• Ruder AM, Moodie PF, Nelson NA, Choi NW. Does family history of breast cancer improve survival among patients with breast cancer? Am J Clin Exp Obstet Gynecol. 1988;158(4):963–968. doi:10.1016/0002-9378(88)90103-2
   Google Scholar
• Trieu PDY, Mello-Thoms C, Peat JK, Do TD, Brennan PC. Risk factors of female breast cancer in Vietnam: a case-control study. Cancer Res Treat. 2017;49(4):990. doi:10.4143/crt.2016.488
   PubMed Web of Science ®Google Scholar
• Tessaro S, B´eria JU, Tomasi E, Victora CG. Breastfeeding and breast cancer: a case-control study in Southern Brazil. Cadernos de Sa´ude P´ublica. 2003;19(6):1593–1601. doi:10.1590/S0102-311X2003000600004
   PubMedGoogle Scholar
• Pakseresht S, Ingle GK, Bahadur AK, et al. Risk factors with breast cancer among women in Delhi. Indian J Cancer. 2009;46(2):132. doi:10.4103/0019-509X.49151
   PubMedGoogle Scholar
• Kwes AAS, Isaac NM, CharlesKojo A, Richard A. Determination of Predictor Variables Contributing to the Survival of Prostate Cancer Patients in Komfo Anokye Teaching Hospital, Ghana. Int J Appl. 2014;4(6).
   Google Scholar